Cargando…

Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials

BACKGROUND: Infection with Human Immunodeficiency virus (HIV) is an important risk factor for Tuberculosis (TB). Anti-Retroviral Therapy (ART) has improved the prognosis of HIV and reduced the risk of TB infected patients. Isoniazid Preventive Therapy (IPT) aims to reduce the development of active T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayele, Henok Tadesse, van Mourik, Maaike S. M., Debray, Thomas P. A., Bonten, Marc J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638336/ https://www.ncbi.nlm.nih.gov/pubmed/26551023 http://dx.doi.org/10.1371/journal.pone.0142290

Ejemplares similares

Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study
por: Ayele, Henok Tadesse, et al.
Publicado: (2015)

Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta–analysis
por: Ayieko, James, et al.
Publicado: (2014)

Isoniazid for preventing tuberculosis in HIV‐infected children
por: Zunza, Moleen, et al.
Publicado: (2017)

Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa
por: Szakacs, Tom A, et al.
Publicado: (2006)

Effectiveness of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme setting
por: Padmapriyadarsini, C., et al.
Publicado: (2020)

Effectiveness of a 6-Month Isoniazid on Prevention of Incident Tuberculosis Among People Living with HIV in Eritrea: A Retrospective Cohort Study
por: Russom, Mulugeta, et al.
Publicado: (2022)

Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV
por: Vojnov, Lara, et al.
Publicado: (2022)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use
por: Hahn, Judith A., et al.
Publicado: (2023)

Adherence to Isoniazid Preventive Therapy among Under-Five Children in Contact with Adult Bacteriologically Confirmed Pulmonary Tuberculosis Patients: A Mixed-Method Study
por: Seid, Getachew, et al.
Publicado: (2020)

Beneficial Effect of Isoniazid Preventive Therapy and Antiretroviral Therapy on the Incidence of Tuberculosis in People Living with HIV in Ethiopia
por: Yirdaw, Kesetebirhan Delele, et al.
Publicado: (2014)

Tuberculosis and isoniazid prophylaxis among adult HIV positive patients on ART in Northwest Ethiopia
por: Geremew, Demeke, et al.
Publicado: (2022)

A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia
por: Datiko, D. G., et al.
Publicado: (2017)

Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients
por: Toure, A., et al.
Publicado: (2016)

Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children
por: Luabeya, Kany Kany A., et al.
Publicado: (2015)

Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe
por: Nyathi, Saziso, et al.
Publicado: (2019)

Isoniazid Preventive Therapy for Tuberculosis in People Living with HIV: A Cross Sectional Study in Butebo, Uganda
por: Oonyu, Lawrence, et al.
Publicado: (2022)

Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts
por: Assefa, Dawit Getachew, et al.
Publicado: (2022)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Malnutrition: Prevalence and its associated factors in People living with HIV/AIDS, in Dilla University Referral Hospital
por: Hailemariam, Solomon, et al.
Publicado: (2013)

Liver Injury Following Isoniazid Preventive Therapy in HIV Patients Attending Halibet National Referral Hospital, Eritrea: A Prospective Cohort Study
por: Russom, Mulugeta, et al.
Publicado: (2023)

The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis
por: Geremew, Demeke, et al.
Publicado: (2019)

Modeling the implementation of population-level isoniazid preventive therapy for tuberculosis control in a high HIV-prevalence setting
por: Rhines, Allison S., et al.
Publicado: (2018)

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Self-reported adherence and associated factors to isoniazid preventive therapy for latent tuberculosis among people living with HIV/AIDS at health centers in Gondar town, North West Ethiopia
por: Ayele, Asnakew Achaw, et al.
Publicado: (2017)

Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia
por: Mindachew, Mesele, et al.
Publicado: (2011)

Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study
por: Sabasaba, Amon, et al.
Publicado: (2019)

Effectiveness of Intravenous Isoniazid and Ethambutol Administration in Patients with Tuberculosis Meningoencephalitis and HIV Infection
por: Butov, Dmytro, et al.
Publicado: (2020)

Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
por: Shayo, Grace A., et al.
Publicado: (2015)

Seizures in an Immunocompetent Adult From Treatment of Latent Tuberculosis Infection: Is Isoniazid to Blame?
por: Navalkele, Bhagyashri, et al.
Publicado: (2020)

Implementing an isoniazid preventive therapy program for people living with HIV in Thailand
por: Danyuttapolchai, Junya, et al.
Publicado: (2017)

Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries
por: Charles, M. Katherine, et al.
Publicado: (2016)

Hepatotoxicity induced by isoniazid in patients with latent tuberculosis infection: a meta-analysis
por: Oscanoa, Teodoro J., et al.
Publicado: (2023)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011)

Isoniazid-induced liver disorder in the treatment of tuberculosis
por: Sivannan, Srinivasan, et al.
Publicado: (2018)

Dose of Isoniazid in Renal Disease for Treatment of Tuberculosis
por: Sarma, G. R. K.
Publicado: (2022)

Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis
por: Agyemang, Nana, et al.
Publicado: (2023)

Isoniazid preventive therapy in HIV-infected pregnant and postpartum women in high prevalence of tuberculosis countries: A protocol for systematic review
por: Wang, Xiaozhuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q0ubj3i9jogd5u78e75v2ute8u